ARCHIVES

On Capitol Hill: Funding Outlook Brighter For NIH and NCI as appropriators Provide Increases

This article is from The Cancer Letter archive.

Vol. 25 No. 37 | October 1, 1999

Download PDF Visit The Full Archive

Related Articles

Phase II Elotuzumab Study Demonstrates 33 Months PFS

July 26, 2013

In Brief: CDP Services Wins ASC Planning Contract; Jury Finds Sarin Guilty of Embezzlement

July 17, 1992

Imaging Technique Identifies Consequences Of Mutation

February 24, 2012

Revlimid Maintenance Therapy Delayed Progression by 90%

May 27, 2011

“Significant changes should be made to reduce redundancy, streamline operations, promote collaboration, and optimize productivity.”

July 14, 1995

Immunoassays For Isoenzymes

April 15, 1983